MedTrace Logo

Safety and Feasibility of Early Discharge for Transfemoral Transcatheter Aortic Valve Replacement

NCT03600935 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 315

Last updated 2018-09-25

No results posted yet for this study

Summary

The primary objective of this study is to determine the efficacy, safety and feasibility of next day discharge home in patients undergoing self-expandable transfemoral TAVR utilizing the Vancouver 3M Clinical Pathway.

Conditions

  • Aortic Valve Stenosis

Interventions

OTHER

Vancouver Clinical Pathway

Vancouver Clinical Pathway

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • BC Centre for Improved Cardiovascular Health

    lead OTHER

Principal Investigators

  • David A Wood, MD · University of British Columbia

  • John A Webb, MD · University of British Columbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2020-09-30
Completion
2021-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600935 on ClinicalTrials.gov